15 February 2021 Priya Vaidya 2048 Case Updates Neurim Pharmaceuticals v Generics UK Limited [2020] EWHC 3270 (Pat) byPriya Vaidya The case: A patent case relating to prolonged release pharmaceutical formulations in which the active ingredient melatonin is intended to improve the restorative quality of sleep in a patient suffering from primary insomnia characterised by non-restorative sleep. The case called for experts in sleep medicine. To continue reading you must be an EWI member, become a member and access exclusive content. Already a member? Login Share Print Tags Bias06. Rules and Regulations11. Report Writing Related articles Working with Expert Witnesses in Serious Injury New Forensic Science Regulator guidance for declaring compliance with the code of practice Presbar Diecastings Limited v GW Atkins & Sons Limited & Anor Neutral Citation Number[2026] EWHC 399 (Ch) Podcast Episode 23: Experts in the Courts What were the effects of repeated sexual abuse at the hands of a schoolteacher? Switch article R (IJ (Kosovo)) v Secretary of State for the Home Department [2020] EWHC 3487 (Admin) Previous Article B v A [2020] EWHC 3138 (Fam) Next Article Comments are only visible to subscribers.